Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
153.45
-1.89 (-1.22%)
Nov 18, 2024, 4:00 PM EST - Market closed
Tenet Healthcare Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for Tenet Healthcare stock have an average target of 160.67, with a low estimate of 81 and a high estimate of 217. The average target predicts an increase of 4.71% from the current stock price of 153.45.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for THC stock from 18 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Buy | 8 | 8 | 8 | 8 | 9 | 9 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 17 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $171 → $190 | Buy | Maintains | $171 → $190 | +23.82% | Nov 8, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $195 → $205 | Buy | Maintains | $195 → $205 | +33.59% | Nov 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $168 → $177 | Buy | Maintains | $168 → $177 | +15.35% | Oct 30, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $173 → $196 | Strong Buy | Maintains | $173 → $196 | +27.73% | Oct 30, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $174 → $183 | Buy | Maintains | $174 → $183 | +19.26% | Oct 30, 2024 |
Financial Forecast
Revenue This Year
21.00B
from 20.55B
Increased by 2.21%
Revenue Next Year
21.60B
from 21.00B
Increased by 2.84%
EPS This Year
11.24
from 5.71
Increased by 96.99%
EPS Next Year
11.75
from 11.24
Increased by 4.51%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 22.2B | 23.2B | 24.4B | ||
| Avg | 21.0B | 21.6B | 22.7B | ||
| Low | 20.2B | 20.5B | 21.4B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.1% | 10.3% | 12.8% | ||
| Avg | 2.2% | 2.8% | 4.9% | ||
| Low | -1.5% | -2.5% | -1.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 12.25 | 13.65 | 15.62 | ||
| Avg | 11.24 | 11.75 | 13.17 | ||
| Low | 8.72 | 9.95 | 10.44 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 114.7% | 21.4% | 33.0% | ||
| Avg | 97.0% | 4.5% | 12.1% | ||
| Low | 52.9% | -11.5% | -11.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.